{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:36:15Z","timestamp":1772012175136,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7,1]]},"DOI":"10.1093\/hmg\/ddh154","type":"journal-article","created":{"date-parts":[[2004,5,17]],"date-time":"2004-05-17T20:13:11Z","timestamp":1084824791000},"page":"1333-1340","source":"Crossref","is-referenced-by-count":122,"title":["Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome"],"prefix":"10.1093","volume":"13","author":[{"given":"Kenji","family":"Amano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Sago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Uchikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana E.","family":"Kotliarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Nukina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,5,11]]},"reference":[{"key":"key\n\t\t\t\t20170522125847_DDH154C1","unstructured":"Epstein, C.J. (2001) Down syndrome (trisomy 21). In Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. (eds), The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw Hill, New York, pp. 1123\u20131256."},{"key":"key\n\t\t\t\t20170522125847_DDH154C2","doi-asserted-by":"crossref","unstructured":"Bahn, S., Mimmack, M., Ryan, M., Caldwell, M.A., Jauniaux, E., Starkey, M., Svendsen, C.N. and Emson, P. (2002) Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet, 359, 310\u2013315.","DOI":"10.1016\/S0140-6736(02)07497-4"},{"key":"key\n\t\t\t\t20170522125847_DDH154C3","doi-asserted-by":"crossref","unstructured":"FitzPatrick, D.R., Ramsay, J., McGill, N.I., Shade, M., Carothers, A.D. and Hastie, N.D. (2002) Transcriptome analysis of human autosomal trisomy. Hum. Mol. Genet., 11, 3249\u20133256.","DOI":"10.1093\/hmg\/11.26.3249"},{"key":"key\n\t\t\t\t20170522125847_DDH154C4","doi-asserted-by":"crossref","unstructured":"Mao, R., Zielke, C.L., Zielke, H.R. and Pevsner, J. (2003) Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics, 81, 457\u2013467.","DOI":"10.1016\/S0888-7543(03)00035-1"},{"key":"key\n\t\t\t\t20170522125847_DDH154C5","doi-asserted-by":"crossref","unstructured":"Chrast, R., Scott, H.S., Papasavvas, M.P., Rossier, C., Antonarakis, E.S., Barras, C., Davisson, M.T., Schmidt, C., Estivill, X., Dierssen, M. et\u00a0al. (2000) The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res., 10, 2006\u20132021.","DOI":"10.1101\/gr.10.12.2006"},{"key":"key\n\t\t\t\t20170522125847_DDH154C6","doi-asserted-by":"crossref","unstructured":"Saran, N.G., Pletcher, M.T., Natale, J.E., Cheng, Y. and Reeves, R.H. (2003) Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum. Mol. Genet., 12, 2013\u20132019.","DOI":"10.1093\/hmg\/ddg217"},{"key":"key\n\t\t\t\t20170522125847_DDH154C7","doi-asserted-by":"crossref","unstructured":"Cox, D.R., Smith, S.A., Epstein, L.B. and Epstein, C.J. (1984) Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): production of viable trisomy 16-diploid mouse chimeras. Dev. Biol., 101, 416\u2013424.","DOI":"10.1016\/0012-1606(84)90156-8"},{"key":"key\n\t\t\t\t20170522125847_DDH154C8","doi-asserted-by":"crossref","unstructured":"Coyle, J.T., Oster-Granite, M.L., Reeves, R.H. and Gearhart, J.D. (1988) Down syndrome, Alzheimer's disease and the trisomy 16 mouse. Trends Neurosci., 11, 390\u2013394.","DOI":"10.1016\/0166-2236(88)90075-6"},{"key":"key\n\t\t\t\t20170522125847_DDH154C9","unstructured":"Davisson, M.T., Schmidt, C. and Akeson, E.C. (1990) Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog. Clin. Biol. Res., 360, 263\u2013280."},{"key":"key\n\t\t\t\t20170522125847_DDH154C10","doi-asserted-by":"crossref","unstructured":"Sago, H., Carlson, E.J., Smith, D.J., Kilbridge, J., Rubin, E.M., Mobley, W.C., Epstein, C.J. and Huang, T.-T. (1998) Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl Acad. Sci. USA, 95, 6256\u20136261.","DOI":"10.1073\/pnas.95.11.6256"},{"key":"key\n\t\t\t\t20170522125847_DDH154C11","doi-asserted-by":"crossref","unstructured":"Sago, H., Carlson, E.J., Smith, D.J., Rubin, E.M., Crnic, L.S., Huang, T.-T. and Epstein, C.J. (2000) Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res., 48, 606\u2013613.","DOI":"10.1203\/00006450-200011000-00009"},{"key":"key\n\t\t\t\t20170522125847_DDH154C12","doi-asserted-by":"crossref","unstructured":"Gardiner, K., Fortna, A., Bechtel, L. and Davisson, M.T. (2003) Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene, 318, 137\u2013147.","DOI":"10.1016\/S0378-1119(03)00769-8"},{"key":"key\n\t\t\t\t20170522125847_DDH154C13","doi-asserted-by":"crossref","unstructured":"Davisson, M.T., Bechtel, L.J., Akeson, E.C., Fortna, A., Slavov, D. and Gardiner, K. (2001) Evolutionary breakpoints on human chromosome 21. Genomics, 78, 99\u2013106.","DOI":"10.1006\/geno.2001.6639"},{"key":"key\n\t\t\t\t20170522125847_DDH154C14","doi-asserted-by":"crossref","unstructured":"Richtsmeier, J.T., Zumwalt, A., Carlson, E.J., Epstein, C.J. and Reeves, R.H. (2002) Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am. J. Med. Genet., 107, 317\u2013324.","DOI":"10.1002\/ajmg.10175"},{"key":"key\n\t\t\t\t20170522125847_DDH154C15","doi-asserted-by":"crossref","unstructured":"Reeves, R.H., Irving, N.G., Moran, T.H., Wohn, A., Kitt, C., Sisodia, S.S., Schmidt, C., Bronson, R.T. and Davisson, M.T. (1995) A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat. Genet., 11, 177\u2013184.","DOI":"10.1038\/ng1095-177"},{"key":"key\n\t\t\t\t20170522125847_DDH154C16","doi-asserted-by":"crossref","unstructured":"Jackson, J.E. (1991) A User's Guide to Principal Components. Wiley-Interscience, New York.","DOI":"10.1002\/0471725331"},{"key":"key\n\t\t\t\t20170522125847_DDH154C17","doi-asserted-by":"crossref","unstructured":"Iyer, V.R., Eisen, M.B., Ross, D.T., Schuler, G., Moore, T., Lee, J.C.F., Trent, J.M., Staudt, L.M., Hudson, J., Jr, Boguski, M.S. et\u00a0al. (1999) The transcriptional program in the response of human fibroblasts to serum. Science, 283, 83\u201387.","DOI":"10.1126\/science.283.5398.83"},{"key":"key\n\t\t\t\t20170522125847_DDH154C18","doi-asserted-by":"crossref","unstructured":"Taniguchi, M., Miura, K., Iwao, H. and Yamanaka, S. (2001) Quantitative assessment of DNA microarrays\u2013comparison with northern blot analyses. Genomics, 71, 34\u201339.","DOI":"10.1006\/geno.2000.6427"},{"key":"key\n\t\t\t\t20170522125847_DDH154C19","doi-asserted-by":"crossref","unstructured":"Yuen, T., Wurmbach, E., Pfeffer, R.L., Ebersole, B.J. and Sealfon, S.C. (2002) Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucl. Acids Res., 30, e48.","DOI":"10.1093\/nar\/30.10.e48"},{"key":"key\n\t\t\t\t20170522125847_DDH154C20","doi-asserted-by":"crossref","unstructured":"Waterston, R.H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J.F., Agarwal, P., Agarwala, R., Ainscough, R., Alexandersson, M., An, P. et\u00a0al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature, 420, 520\u2013562.","DOI":"10.1038\/nature01262"},{"key":"key\n\t\t\t\t20170522125847_DDH154C21","doi-asserted-by":"crossref","unstructured":"Pritchard, M.A. and Kola, I. (1999) The \u2018gene dosage effect\u2019 hypothesis versus the \u2018amplified developmental instability\u2019 hypothesis in Down syndrome. J. Neural Transm. Suppl., 57, 293\u2013303.","DOI":"10.1007\/978-3-7091-6380-1_20"},{"key":"key\n\t\t\t\t20170522125847_DDH154C22","doi-asserted-by":"crossref","unstructured":"Epstein, C.J. (1986) The Consequences of Chromosome Imbalance: Principles, Mechanisms, and Models. Cambridge University Press, New York.","DOI":"10.1017\/CBO9780511529702"},{"key":"key\n\t\t\t\t20170522125847_DDH154C23","doi-asserted-by":"crossref","unstructured":"Cheon, M.S., Kim, S.H., Yaspo, M.-L., Blasi, F., Aoki, Y., Melen, K. and Lubec, G. (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I). Amino Acids, 24, 111\u2013117.","DOI":"10.1007\/s00726-003-0009-9"},{"key":"key\n\t\t\t\t20170522125847_DDH154C24","doi-asserted-by":"crossref","unstructured":"Cheon, M.S., Bajo, M., Kim, S.H., Claudio, J.O., Stewart, A.K., Patterson, D., Kruger, W.D., Kondoh, H. and Lubec, G. (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II). Amino Acids, 24, 119\u2013125.","DOI":"10.1007\/s00726-003-0009-9"},{"key":"key\n\t\t\t\t20170522125847_DDH154C25","doi-asserted-by":"crossref","unstructured":"Cheon, M.S., Kim, S.H., Ovod, V., Kopitar Jerala, N., Morgan, J.I., Hatefi, Y., Ijuin, T., Takenawa, T. and Lubec, G. (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III). Amino Acids, 24, 127\u2013134.","DOI":"10.1007\/s00726-003-0009-9"},{"key":"key\n\t\t\t\t20170522125847_DDH154C26","doi-asserted-by":"crossref","unstructured":"Cheon, M.S., Shim, K.S., Kim, S.H., Hara, A. and Lubec, G. (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part IV). Amino Acids, 25, 41\u201347.","DOI":"10.1007\/s00726-003-0009-9"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/13\/13\/1333\/17240737\/ddh154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T11:58:50Z","timestamp":1526644730000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddh154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,11]]},"references-count":26,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2004,5,11]]},"published-print":{"date-parts":[[2004,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddh154","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5,11]]}}}